This is an issue when it comes to generalizability of findings from the STEP trials to how the drug may be used in clinical practice in Canada
Understanding why tirzepatide may not be working requires examining multiple factors: treatment duration, dosing adequacy, individual metabolic variability, medication adherence, lifestyle behaviors, and potential drug interactions
Although these figures do not allow for an apples-to-apples comparison, they clearly represent a fairly wide coverage range, with KFF reporting much lower rates of semaglutide and GLP-1 coverage than Mercer, but this data discrepancy can perhaps be explained in part by the 31% of KFF survey respondents who stated they did not know whether their employers largest health plan covered these medications for weight loss treatment
However, when considering semaglutide for women, reproductive health is a paramount consideration
Why do some people say you can freeze other medications but not this one
One of the most controversial is gene therapy designed to program the body to produce its own GLP-1 hormone for years after a single treatment
